The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company developing bioprinted tissue therapeutics.

Total Raised

$286 M

Rounds

8

Links

Verticals

Artificial Intelligence (AI)
Biotechnology
Life Science

Investment History

  1. Grant

    Apr 2026

    $17M

  2. Series B

    Jan 2025

    $115M

  3. Grant

    Jul 2024

    $53M

  4. Series A

    Jan 2020

    $20M

  5. Grant

    Nov 2018

    $2M

Team

Tamer Mohamed

Co-founder & CEO

Sam Wadsworth

Co-founder & Chief Scientific Officer

Simon Beyer

Co-founder & Chief Technology Officer

Spiro Getsios

Senior VP, Preclinical R&D